Latest Commercialization News

Dalaroo Metals’ maiden sampling at Blue Lagoon reveals a district-scale critical minerals system with high-grade zirconium, hafnium, and rare earth elements over a 2.7km strike. The results validate historical data and position the project as a strategic asset in Greenland’s emerging critical minerals landscape.

1414 Degrees secures critical approvals from AEMO and ElectraNet for its 140 MW Aurora Battery Energy Storage System, advancing the project toward grid connection and commercial operation in 2026.

Noble Helium has received a further unsecured loan of AUD 250,000 from its Executive Chair to support working capital, highlighting management’s confidence amid ongoing refinancing efforts.

Wellnex Life reports a $2.4 million EBITDA improvement in H1 FY26 and reaches breakeven by Q2, supported by strong Pain Away sales and expanded distribution.

Orthocell has increased its investment in Marine Biomedical to 11.7%, securing exclusive distribution rights to the innovative PearlBone™ technology as it nears FDA approval.

Proteomics International has been granted a Canadian patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma. This milestone strengthens its global intellectual property portfolio and paves the way for commercial expansion in North America.

Osteopore Limited has secured an exclusive multi-year distribution agreement with Majeton to commercialise its dental and maxillofacial products in China, Hong Kong, and Macau, marking a major step in its Asia-Pacific expansion.

Oneview Healthcare reported a stronger cash position in Q4 2025 alongside a key expansion of its US footprint through a new partnership with a Top 10 health system. The company’s strategic moves set the stage for growth in 2026.

4DMedical Limited has raised $150 million through a well-supported institutional placement to accelerate the commercialisation of its innovative lung imaging product CT – VQ™ in the US market. The capital raise comes with minimal dilution and increased insider confidence.

Clarity Pharmaceuticals confirms continuation of its SECuRE Phase II trial for Cu-SAR-bisPSMA without protocol changes, reporting encouraging safety and efficacy data in metastatic prostate cancer patients.

Patagonia Lithium’s latest drilling at Formentera reached 401m, revealing promising lithium concentrations at shallower depths but encountering low-porosity clays that limited further progress. The findings refine the company’s geological understanding and set the stage for upcoming drilling.

Wia Gold has appointed mining veteran Henk Diederichs as Managing Director and CEO, signaling a strategic shift as the Kokoseb Gold Project in Namibia moves toward a Definitive Feasibility Study.